article thumbnail

Tech to Help Reach Your 2024 Fitness Goals

PM360

If losing weight or just getting more fit is on your agenda for 2024 then you may be looking at investing in some new exercise gear. The device is portable, lightweight, and can be used on a variety of surfaces to help you tone and train everything from triceps to calves to quads and more.

article thumbnail

Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine

Pharmaceutical Technology

The vaccine demonstrated a similar safety profile to Pfizer’s marketed 20-serotype shot Prevnar 20 at all assessed doses, and showed non-inferior efficacy. There, the business plans to submit an IND application for a Phase I/II in the second half of 2023, with a readout in 2024. Competition in an increasingly heated market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

If a Covered Entity or Business Associate is using PHI in model development (training data for example), deployment, or maintenance of a healthcare AI system, then HIPAA obligations likely apply. Implementation of risk management practices for all predictive DSIs, ensuring their validity, reliability, safety, security, and effectiveness.

article thumbnail

Endotoxin testing: the international regulatory landscape

European Pharmaceutical Review

At Roche, we see it as our ethical and environmental responsibility to support the use of alternative methods that prioritise animal welfare while ensuring the safety of our patients and the quality of our products. in the monographs for Water for Injection (0169) and Purified Water (0008) on 1 April 2024. on 1 January 2024.

Ethics 85
article thumbnail

Vaccine demonstrates benefit in delaying cancer relapse

European Pharmaceutical Review

The AMPLIFY-201 clinical trial evaluating the off-the-shelf cancer vaccine ELI-002 was designed to lower the risk relapse by ‘training’ T cells to recognise KRAS mutations and therefore eliminate KRAS-mutant cells, the team noted. It also showed a favourable safety profile, which is exciting.”

article thumbnail

Rare disease spotlight: first EU-approved treatment for Friedreich’s ataxia

European Pharmaceutical Review

For Rare Disease Day 2024, Biogen’s Vice President and Head of the Neuromuscular Development Unit, Dr Toby Ferguson, spoke with EPR about the current rare disease landscape, including highlighting recent developments in treating Friedreich’s ataxia.

article thumbnail

Breaking Down Malaysia's Budget 2023

Contrarian Sales Techniques

The Luxury Goods Tax is being implemented this year, and a Capital Gains Tax on unlisted shares may be introduced in 2024. RM1 billion will be allocated to strengthen domestic safety, including acquiring more than 2,100 units of body cameras for the Royal Malaysia Police. Economic growth and tax policies: The government predicts a 4.5%